RAN and cancer: In a subgroup analysis targeting cancer type, the combined RAN rs14035 CT + TT genotype was associated with decreased risk of rectal cancer (AOR = 0.640; 95% CI, 0.430–0.954; P = 0.028), but not colon cancer (Table 3).